Promising Penny Stocks To Watch In November 2024

In This Article:

Global markets have been experiencing significant shifts, with U.S. stocks rallying to record highs following a Republican electoral sweep and a Federal Reserve rate cut that has influenced investor sentiment. In this context, penny stocks—often representing smaller or emerging companies—continue to capture attention due to their potential for growth and value. While the term may seem outdated, these stocks can still offer opportunities when backed by strong financials and promising business models.

Top 10 Penny Stocks

Name

Share Price

Market Cap

Financial Health Rating

BP Plastics Holding Bhd (KLSE:BPPLAS)

MYR1.24

MYR349.03M

★★★★★★

Lever Style (SEHK:1346)

HK$0.83

HK$526.87M

★★★★★★

DXN Holdings Bhd (KLSE:DXN)

MYR0.49

MYR2.44B

★★★★★★

Rexit Berhad (KLSE:REXIT)

MYR0.785

MYR135.97M

★★★★★★

Embark Early Education (ASX:EVO)

A$0.755

A$138.53M

★★★★☆☆

Polar Capital Holdings (AIM:POLR)

£4.955

£477.59M

★★★★★★

Hil Industries Berhad (KLSE:HIL)

MYR0.88

MYR292.11M

★★★★★★

Shoe Zone (AIM:SHOE)

£1.525

£70.5M

★★★★★★

Kelington Group Berhad (KLSE:KGB)

MYR3.00

MYR2.07B

★★★★★☆

Next 15 Group (AIM:NFG)

£3.80

£377.93M

★★★★☆☆

Click here to see the full list of 5,745 stocks from our Penny Stocks screener.

We'll examine a selection from our screener results.

Gilston Group

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Gilston Group Limited, with a market cap of HK$775.57 million, is an investment holding company that designs, manufactures, and sells finished zippers and other garment accessories for original equipment manufacturers of apparel brands and labels.

Operations: The company generates revenue primarily from the manufacture and sales of zippers, amounting to HK$225.41 million.

Market Cap: HK$775.57M

Gilston Group Limited has shown a significant increase in revenue, reporting HK$160.39 million for the first half of 2024, up from HK$123.39 million the previous year. The introduction of a property management business contributed HK$45.27 million to this growth, although gains were offset by losses on asset disposals and increased tax expenses. Despite being unprofitable with negative return on equity, Gilston's short-term assets comfortably cover both its short and long-term liabilities. The company benefits from an experienced management team and board but has seen shareholder dilution recently due to an increase in shares outstanding by 3%.

SEHK:2011 Revenue & Expenses Breakdown as at Nov 2024
SEHK:2011 Revenue & Expenses Breakdown as at Nov 2024

Tianjin TEDA Biomedical Engineering

Simply Wall St Financial Health Rating: ★★★★☆☆